๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Oral tetrahydroaminoacridine and lecithin treatment of Alzheimer's disease

Book ID
123275329
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
151 KB
Volume
11
Category
Article
ISSN
0197-4580

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Tetrahydroaminoacridine and lecithin in
Tetrahydroaminoacridine and lecithin in the treatment of Alzheimer's disease
โœ Henry C. Weinstein; Saskia Teunisse; Willem A. Gool ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 529 KB

In 12 ambulant patients with a clinical diagnosis of probable Alzheimer's disease, a 12-week, double-blind, placebo-controlled study with 100 mg/day tetrahydroaminoacridine (THA) and 10 g/day lecithin is reported. The aim of the study was to find whether treatment would result in an improvement of c

TETRAHYDROAMINOACRIDINE AND ALZHEIMER'S
TETRAHYDROAMINOACRIDINE AND ALZHEIMER'S DISEASE
โœ Katona, CorneliusL.E.; O'Brien, Catherine; Tyrrell, P.; Hardy, J.; Rossor, M.; W ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› The Lancet ๐ŸŒ English โš– 347 KB
Tetrahydroaminoacridine in Alzheimer's d
Tetrahydroaminoacridine in Alzheimer's disease
โœ B. Davies; D. Andrewes; R. Stargatt; D. Ames; V. Tuckwell; S. Davis ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 445 KB ๐Ÿ‘ 1 views

Tetrahydroaminoacridine (THA), a centrally acting anticholinesterase, was used in a two-month, double-blind, placebo-controlled crossover trial to treat 10 patients meeting DSM-111-R criteria for dementia of the Alzheimer type. Eight patients continued to take THA for a further three months. Nausea